ibt – immunological and biochemical testsystems GmbH: innovative tools for functional proteomics are our target!
Infectious Disease Antigens
CMV glycoprotein p50, recombinant antigen
Recombinant Cytomegalovirus glycoprotein p50
Product Specifications CMV gp p50:
Biological activity: Protein made in E. coli as a fusion with human superoxide dismutase (SOD). It covers from Met 1 to Gly 433 of the glycoprotein p50 of the CMV AD169 strain. The apparent MW is 62,000. The protein is purified by ionic -exchange followed by gel filtration chromatography.
Purity: Over 85%.
Stability: Stable at -20°C for at least 6 months.
Formulation: Solution at 0.50 mg/ml in PBS, 0.1% SDS, 1mM EDTA (pH 7.4). References:
1. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. M.S. Chee et al. In Current Topics in Microbiology and Immunology. Vol. 154. Springer-Verlag, Berlin, Heidelberg 1990. pp. 125-169.
Datasheet for CMV glycoprotein p50, recombinant antigen